{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:45:58Z","timestamp":1788486358363,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,13]]},"DOI":"10.7759\/cureus.17938","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T14:54:41Z","timestamp":1631544881000},"source":"Crossref","is-referenced-by-count":17,"title":["Cardiovascular Risk Associated With TNF Alpha Inhibitor Use in Patients With Rheumatoid Arthritis"],"prefix":"10.7759","author":[{"given":"Aaiz","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Targol","family":"Tarahomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Bollampally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Heydari-Kamjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen JS","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016, 388:2023-38. 10.1016\/s0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3726-1","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014","volume":"37","author":"Hunter TM","year":"2017","unstructured":"Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int. 2017, 37:1551-7. 10.1007\/s00296-017-3726-1","journal-title":"Rheumatol Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson C","year":"2003","unstructured":"Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003, 62:722-7. 10.1136\/ard.62.8.722","journal-title":"Ann Rheum Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-012-8346-7","article-title":"Genetics of rheumatoid arthritis - a comprehensive review","volume":"45","author":"Kurk\u00f3 J","year":"2013","unstructured":"Kurk\u00f3 J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z. Genetics of rheumatoid arthritis - a comprehensive review. Clin Rev Allergy Immunol. 2013, 45:170-9. 10.1007\/s12016-012-8346-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2235042X19853484","article-title":"Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: a nationwide register study","volume":"9","author":"L\u00f8ppenthin K","year":"2019","unstructured":"L\u00f8ppenthin K, Esbensen BA, \u00d8stergaard M, Ibsen R, Kjellberg J, Jennum P. Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: a nationwide register study. J Comorb. 2019, 9:1-7. 10.1177\/2235042X19853484","journal-title":"J Comorb"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/371909","article-title":"Cardiovascular disease in rheumatoid arthritis: a systematic literature review in Latin America","volume":"2012","author":"Sarmiento-Monroy JC","year":"2012","unstructured":"Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-D\u00edaz C, Anaya J-M, Rojas-Villarraga A. Cardiovascular disease in rheumatoid arthritis: a systematic literature review in Latin America. Arthritis. 2012, 2012:1-17. 10.1155\/2012\/371909","journal-title":"Arthritis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu224","article-title":"Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment","volume":"53","author":"Choy E","year":"2014","unstructured":"Choy E, Ganeshalingam K, Semb AG, Szekanecz Z, Nurmohamed M. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford). 2014, 53:2143-54. 10.1093\/rheumatology\/keu224","journal-title":"Rheumatology (Oxford)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby P","year":"2008","unstructured":"Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med. 2008, 121:S21-31. 10.1016\/j.amjmed.2008.06.014","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.99.11.1492","article-title":"Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium","volume":"99","author":"Irwin MW","year":"1999","unstructured":"Irwin MW, Mak S, Mann DL, et al.. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation. 1999, 99:1492-8. 10.1161\/01.cir.99.11.1492","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(99)00600-2","article-title":"The role of tumor necrosis factor in the pathophysiology of heart failure","volume":"35","author":"Feldman AM","year":"2000","unstructured":"Feldman AM, Combes A, Wagner D, et al.. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000, 35:537-44. 10.1016\/s0735-1097(99)00600-2","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00478","article-title":"TNF receptor 2 and disease: autoimmunity and regenerative medicine","volume":"4","author":"Faustman DL","year":"2013","unstructured":"Faustman DL, Davis M. TNF receptor 2 and disease: autoimmunity and regenerative medicine. Front Immunol. 2013, 4:478. 10.3389\/fimmu.2013.00478","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2016.03.009","article-title":"TRAF2 multitasking in TNF receptor-induced signaling to NF-\u03baB, MAP kinases and cell death","volume":"116","author":"Borghi A","year":"2016","unstructured":"Borghi A, Verstrepen L, Beyaert R. TRAF2 multitasking in TNF receptor-induced signaling to NF-\u03baB, MAP kinases and cell death. Biochem Pharmacol. 2016, 116:1-10. 10.1016\/j.bcp.2016.03.009","journal-title":"Biochem Pharmacol"},{"key":"ref13","article-title":"Congestive Heart Failure","author":"Malik A","year":"2021","unstructured":"Malik A, Brito D, Chhabra L. Congestive Heart Failure. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.300268","article-title":"Epidemiology of heart failure","volume":"113","author":"Roger VL","year":"2013","unstructured":"Roger VL. Epidemiology of heart failure. Circ Res. 2013, 113:646-59. 10.1161\/CIRCRESAHA.113.300268","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui AL","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011, 8:30-41. 10.1038\/nrcardio.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/15.suppl_d.2","article-title":"Differentiation between systolic and diastolic dysfunction","volume":"15","author":"Federmann M","year":"1994","unstructured":"Federmann M, Hess OM. Differentiation between systolic and diastolic dysfunction. Eur Heart J. 1994, 15:2-6. 10.1093\/eurheartj\/15.suppl_d.2","journal-title":"Eur Heart J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug BA","year":"2011","unstructured":"Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011, 123:2006-14. 10.1161\/CIRCULATIONAHA.110.954388","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141647","article-title":"Increased prevalence of diastolic heart failure in patients with rheumatoid arthritis correlates with active disease, but not with treatment type","volume":"42","author":"Schau T","year":"2015","unstructured":"Schau T, Gottwald M, Arbach O, et al.. Increased prevalence of diastolic heart failure in patients with rheumatoid arthritis correlates with active disease, but not with treatment type. J Rheumatol. 2015, 42:2029-37. 10.3899\/jrheum.141647","journal-title":"J Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8070938","article-title":"Current therapeutic options in the treatment of rheumatoid arthritis","volume":"8","author":"K\u00f6hler BM","year":"2019","unstructured":"K\u00f6hler BM, G\u00fcnther J, Kaudewitz D, Lorenz HM. Current therapeutic options in the treatment of rheumatoid arthritis. J Clin Med. 2019, 8:938. 10.3390\/jcm8070938","journal-title":"J Clin Med"},{"key":"ref20","article-title":"Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate","volume":"30","author":"Wolfe F","year":"2003","unstructured":"Wolfe F, Michaud K, Stephenson B, Doyle J. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate. J Rheumatol. 2003, 30:1725-32.","journal-title":"J Rheumatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3892\/br.2012.42","article-title":"TNF inhibitor therapy for rheumatoid arthritis","volume":"1","author":"Ma X","year":"2013","unstructured":"Ma X, Xu S. TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep. 2013, 1:177-84. 10.3892\/br.2012.42","journal-title":"Biomed Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103267","article-title":"Complexity of TNF-\u03b1 signaling in heart disease","volume":"9","author":"Rolski F","year":"2020","unstructured":"Rolski F, B\u0142yszczuk P. Complexity of TNF-\u03b1 signaling in heart disease. J Clin Med. 2020, 9:3267. 10.3390\/jcm9103267","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL)","volume":"109","author":"Mann DL","year":"2004","unstructured":"Mann DL, McMurray JJ, Packer M, et al.. Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL). Circulation. 2004, 109:1594-602. 10.1161\/01.CIR.0000124490.27666.B2","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial","volume":"107","author":"Chung ES","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation. 2003, 107:3133-40. 10.1161\/01.CIR.0000077913.60364.D2","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-9740.2005.04502.x","article-title":"TNF-alpha inhibitors and congestive heart failure","volume":"4","author":"Behnam SM","year":"2005","unstructured":"Behnam SM, Behnam SE, Koo JY. TNF-alpha inhibitors and congestive heart failure. Skinmed. 2005, 4:363-8. 10.1111\/j.1540-9740.2005.04502.x","journal-title":"Skinmed"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22783","article-title":"2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh JA","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, et al.. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016, 68:1-25. 10.1002\/acr.22783","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061739","article-title":"Bimodal function of anti-TNF treatment: shall we be concerned about anti-TNF treatment in patients with rheumatoid arthritis and heart failure?","volume":"19","author":"Kotyla PJ","year":"2018","unstructured":"Kotyla PJ. Bimodal function of anti-TNF treatment: shall we be concerned about anti-TNF treatment in patients with rheumatoid arthritis and heart failure?. Int J Mol Sci. 2018, 19:1739. 10.3390\/ijms19061739","journal-title":"Int J Mol Sci"},{"key":"ref28","article-title":"TNF-\u03b1 in the cardiovascular system: from physiology to therapy","volume":"7","author":"Urschel K","year":"2015","unstructured":"Urschel K, Chicha I. TNF-\u03b1 in the cardiovascular system: from physiology to therapy. Int J Interferon Cytokine Mediat Res. 2015, 7:9-25.","journal-title":"Int J Interferon Cytokine Mediat Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119114","article-title":"Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death","volume":"98","author":"Krown KA","year":"1996","unstructured":"Krown KA, Page MT, Nguyen C, et al.. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996, 98:2854-65. 10.1172\/JCI119114","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.09.004","article-title":"TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma","volume":"4","author":"Sarzi-Puttini P","year":"2005","unstructured":"Sarzi-Puttini P, Atzeni F, Shoenfeld Y, Ferraccioli G. TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma. Autoimmun Rev. 2005, 4:153-61. 10.1016\/j.autrev.2004.09.004","journal-title":"Autoimmun Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/70969-cardiovascular-risk-associated-with-tnf-alpha-inhibitor-use-in-patients-with-rheumatoid-arthritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:02Z","timestamp":1707507242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/70969-cardiovascular-risk-associated-with-tnf-alpha-inhibitor-use-in-patients-with-rheumatoid-arthritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.17938","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,13]]}}}